Poster Session 2-1 PRCA/Iron metabolism

Sat. Oct 12, 2019 5:10 PM - 5:45 PM Poster (Tokyo International Forum, B2F Hall E)

Chair: Fumihiro Ishida (Department of Biomedical Laboratory Medicine, Shinshu University School of Medicine, Japan)

+Add all to schedule

[PS2-1-1] Two cases of acquired PRCA associated with malignant lymphomas

Shin Hasegawa¹, Jun Kimura¹, Hideo Harigae² (1.Hematology, Yamagata City Hospital Saiseikan, Yamagata, Japan, 2.Hematology and Rheumatology, Tohoku Univ., Sendai, Japan)

[PS2-1-2] Somatic mutations of myeloid malignancy-associated genes in acquired pure red cell aplasia (PRCA)

Junki Kohmaru¹, Souichi Koyota¹, Keiji Kuba², Naohito Fujishima³, Tomoo Saga⁴, Ayumi Omokawa⁴, Shigeharu Ueki⁴, Fumihiro Ishida⁵, Shinji Nakao⁶, Akira Matsuda⁷, Akiko Ohta⁸, Kaoru Tohyama⁹, Ryuji Suzuki¹⁰, Kinuko Mitani¹¹, Makoto Hirokawa⁴ (1.Akita University Bioscience Education and Research Center, Akita, Japan, 2.Bioregulatory Medicine, Akita University Graduate School of Medicine, Akita, Japan, 3.Division of Blood Transfusion, Akita University Hospital, Akita, Japan, 4.General Internal Medicine/Clinical Laboratory Medicine, Akita University, Akita, Japan, 5.Department of Biomedical Laboratory Medicine, Shinshu University, Matsumoto, Japan, 6.Department of Cellular Transplantation Biology, Kanazawa University, Kanazawa, Japan, 7.Hemato-Oncology, International Medical Center, Saitama Medical University, Saitama, Japan, 8.Department of Social Medicine, Saitama Medical University, Saitama, Japan, 9.Department of Laboratory Medicine, Kawasaki Medical School, Okayama, Japan, 10.Repertoire Genesis Incorporation, Ibaraki, Japan, 11.Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan)

[PS2-1-3] A case of pure red cell aplasia associated with multiple myeloma treated with cyclosporine A

Mariko Ueno, Kyoko Itakusu, Yukihiro Miyazaki, Koichi Nakase, Yuichiro Nawa (Ehime Prefectural Central Hospital)

[PS2-1-4] Lymphoproliferative diseases related PRCA may be hidden behind EPO-refractory anemia in dialysis

Kentaro Yoshinaga, Masayuki Shiseki, Mari Ohwashi, Mayuko Ishii, Shotaro Hagiwara, Naoki Mori, Junji Tanaka (Dept. of Hematol., Tokyo Women's Univ., Tokyo, Japan)

[PS2-1-5] The hematologist should suspect hereditary hemorrhagic telangiectasia as cause of iron deficiency

Hiroshi Yamasaki (Hematology and Oncology, Kumamoto City Hospital, Kumamoto, Japan)

[PS2-1-6] The effects of Fe-containing phosphate binders on the CKD-MBD and anemia in the elderly HD patients

Kenji Orimoto (General practice of internal medicine, Fureai Higashi-Totsuka Hospital, Yokohama, Japan)

[PS2-1-7] Hereditary hemochromatosis-related gene mutation analysis in Japan

Takeshi Saito¹, Yasumichi Toki¹, Nobue Tamamura¹, Takuya Funayama¹, Sho Igarashi¹, Masatomo Ishioh¹, Mayumi Hatayama¹, Motohiro Shindo¹, Katsuya Ikuta¹, Yoshihiro Torimoto², Yasuaki Tatsumi³, Ayako Kato³, Hisao Hayashi³, Koichi Kato³, Toshikatsu Okumura¹ (1.Division of Gastroenterology and Hematology/Oncology, Asahikawa Medical University, Asahikawa, Hokkaido, Japan, 2.Oncology Center, Asahikawa Medical University Hospital, Asahikawa, Hokkaido, Japan, 3.Laboratory of Medicine, Aichi-Gakuin University School of Pharmacy, Nagoya, Aichi)